These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37395000)

  • 41. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
    Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation of gastric cancer screening - the global experience.
    Leja M; You W; Camargo MC; Saito H
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1093-106. PubMed ID: 25439074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of macrophage inhibitory cytokine 1 as a novel prognostic biomarkers for early gastric cancer screening.
    Ge X; Zhang X; Ma Y; Chen S; Chen Z; Li M
    J Clin Lab Anal; 2021 Jan; 35(1):e23568. PubMed ID: 32918498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
    Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
    Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary
    Chen WD; Zhang X; Zhang MJ; Zhang YP; Shang ZQ; Xin YW; Zhang Y
    World J Gastroenterol; 2022 Aug; 28(30):4120-4132. PubMed ID: 36157109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
    Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
    Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical application and detection techniques of liquid biopsy in gastric cancer.
    Ma S; Zhou M; Xu Y; Gu X; Zou M; Abudushalamu G; Yao Y; Fan X; Wu G
    Mol Cancer; 2023 Jan; 22(1):7. PubMed ID: 36627698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers of gastric cancer: Current topics and future perspective.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2018 Jul; 24(26):2818-2832. PubMed ID: 30018477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility of Plasma-Methylated
    Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
    Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.
    Huang L; Xu A
    Front Med; 2017 Mar; 11(1):20-31. PubMed ID: 28213880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
    Li Y; Sun H; Guan J; Ji T; Wang X
    Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNAs in the gastric juice of gastric cancer patients.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
    Pathol Res Pract; 2018 Sep; 214(9):1239-1246. PubMed ID: 30078471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
    Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-Invasive Early Molecular Detection of Gastric Cancers.
    Yamamoto H; Watanabe Y; Sato Y; Maehata T; Itoh F
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer.
    Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z
    Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current and future molecular diagnostics of gastric cancer.
    Choi RS; Lai WYX; Lee LTC; Wong WLC; Pei XM; Tsang HF; Leung JJ; Cho WCS; Chu MKM; Wong EYL; Wong SCC
    Expert Rev Mol Diagn; 2019 Oct; 19(10):863-874. PubMed ID: 31448971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.